摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-苯基哌啶盐酸盐 | 19509-09-2

中文名称
3-苯基哌啶盐酸盐
中文别名
——
英文名称
3-Phenylpiperidine hydrochloride
英文别名
3-phenyl-piperidine; hydrochloride;3-Phenyl-piperidin; Hydrochlorid;3-phenylpiperidine;hydrochloride
3-苯基哌啶盐酸盐化学式
CAS
19509-09-2
化学式
C11H15N*ClH
mdl
——
分子量
197.708
InChiKey
OKVMJYYCFLIGFJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    141-143 °C
  • 沸点:
    84-88 °C(Press: 0.06 Torr)

计算性质

  • 辛醇/水分配系数(LogP):
    2.58
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    12
  • 氢给体数:
    2
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2933399090

SDS

SDS:efa9a9e8f0d628f4937233cfdf4bde91
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 3-Phenylpiperidine, HCl
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 3-Phenylpiperidine, HCl
CAS number: 19509-09-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H15N.ClH
Molecular weight: 197.7

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    3-苯基哌啶盐酸盐 甲醇ammonia methanol 作用下, 以 甲醇 为溶剂, 50.0 ℃ 、55.15 MPa 条件下, 反应 96.0h, 生成 3-cyclohexylpiperidine
    参考文献:
    名称:
    DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONISTS
    摘要:
    本发明揭示了一种式(I)的化合物,其中变量X1至X10,R1至R7包括R3′,E,v,y,z,A和B如所述,或其药学上可接受的盐,溶剂合物,对映体,外消旋体,非对映体异构体或其混合物,用于治疗、预防或改善肥胖和相关疾病。
    公开号:
    US20080255152A1
点击查看最新优质反应信息

文献信息

  • 咪唑酮类衍生物、其药物组合物和用途
    申请人:北京富龙康泰生物技术有限公司
    公开号:CN104411706B
    公开(公告)日:2016-11-16
    本申请涉及咪唑酮类化合物、其药学可接受的盐、溶剂化物、多晶形物或前药,还涉及包含上述物质的药物组合物和用于预防和治疗蛋白激酶相关性疾病如癌症、代谢疾病、心血管疾病等的用途。
  • SULTAM DERIVATIVES
    申请人:Anderson Kevin W.
    公开号:US20110124686A1
    公开(公告)日:2011-05-26
    The present invention relates to compounds according to formula 1, which exhibit cytotoxic activity. The compounds may be used in the treatment of cancer.
    本发明涉及符合式1的化合物,具有细胞毒活性。这些化合物可用于治疗癌症。
  • Novel Compounds
    申请人:Cheng Yun-Xing
    公开号:US20070259888A1
    公开(公告)日:2007-11-08
    Compounds of Formulae I, or pharmaceutically acceptable salts thereof: wherein X, R 1 , R 2 and R 3 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    公式I的化合物,或其药用盐:其中X、R1、R2和R3如规范中定义的那样,以及包括这些化合物的盐和药物组合物已经准备好。它们在治疗中很有用,特别是在疼痛管理中。
  • [EN] DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONIST<br/>[FR] DIARYLE ETHERS UTILISES EN TANT QU'ANTAGONISTES DE RECEPTEUR OPIOIDES
    申请人:LILLY CO ELI
    公开号:WO2004026305A1
    公开(公告)日:2004-04-01
    A compound of the formula (I) wherein the variables X1 to X10, R1 to R7 including R3', E, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed.
    公式(I)的化合物,其中变量X1至X10,R1至R7包括R3',E,v,y,z,A和B如所述,或其药用盐,溶剂化物,对映体,消旋体,非对映异构体或其混合物,用于治疗、预防或改善肥胖和相关疾病。
  • Diaryl ethers as opioid receptor antagonist
    申请人:Blanco-Pillado Maria-Jesus
    公开号:US20060217372A1
    公开(公告)日:2006-09-28
    A compound of the formula (I) wherein the variables X 1 to X 10 , R 1 to R 7 including R 3′ , E, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed.
    本发明公开了一种化合物(I)的公式,其中变量X1至X10,R1至R7包括R3',E,v,y,z,A和B如所述,或其药学上可接受的盐,溶剂合物,对映体,外消旋体,非对映体异构体或其混合物,用于治疗、预防或缓解肥胖和相关疾病。
查看更多